{
    "nctId": "NCT01157026",
    "briefTitle": "A Pilot Clinical Trial With Tocotrienol on Breast Cancer",
    "officialTitle": "Effectiveness of Tocotrienol-rich Fraction Combined With Tamoxifen in the Management of Women With Early Breast Cancer: A Pilot Clinical Trial",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 240,
    "primaryOutcomeMeasure": "breast cancer specific survival",
    "eligibilityCriteria": "Inclusion criteria:\n\n1. women with estrogen receptor positive tumors.\n2. 40-60 years of age at the start of the tamoxifen therapy.\n3. histologically confirmed primary breast cancer.\n4. a tumor that was positive for estrogen receptors, progesterone receptors, or both.\n5. an Eastern Cooperative Oncology Group performance status of 0,1, or 2 (scored on a scale of 0 to 5, with lower scores indicating better function).\n\nExclusion criteria:\n\n1. concurrent use of investigational drugs and estrogen receptor status negative or unknown.",
    "sex": "FEMALE",
    "minimumAge": "40 Years",
    "stdAges": "ADULT"
}